Autologous Intravenous Mononuclear Stem Cell Therapy in Chronic Ischemic Stroke

Background: The regenerative potential of brain has led to emerging therapies that can cure clinico-motor deficits after neurological diseases. Bone marrow mononuclear cell therapy is a great hope to mankind as these cells are feasible, multipotent and aid in neurofunctional gains in Stroke patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhasin, A, Srivastava, MV, Bhatia, R, Mohanty, S, Kumaran, SS, Bose, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Stem Cells and Regenerative Medicine 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908296/
https://www.ncbi.nlm.nih.gov/pubmed/24693196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908296/
https://www.ncbi.nlm.nih.gov/pubmed/24693196

Ejemplares similares